Eurofins Viracor Introduces Expanded Immune Monitoring Tests for Transplant Patients

Eurofins Viracor Enhances Immune Testing Capabilities

In a promising development for both clinicians and patients, Eurofins Viracor has announced the launch of three new plasma-based assays designed to support immune monitoring in transplant recipients and immunocompromised patients. These assays, which include CXCL9, CXCL10, and Interleukin-18 (IL-18), aim to enhance the accuracy and efficiency of immune assessments crucial for the management of transplant-related health.

Clinical Significance of New Assays

The introduction of these assays is particularly timely as they provide essential data on key immune signaling biomarkers. CXCL9 and CXCL10 are recognized for their role in T cell-mediated immune activation, while IL-18 serves as a critical link between innate and adaptive immunity. This is vital knowledge for managing conditions such as allograft injury, acute rejection, and chronic graft dysfunction. The availability of these markers assists healthcare professionals in making informed decisions regarding patient care and intervention strategies.

Rapid Turnaround for Timely Monitoring

One of the standout features of these new assays is the expedited turnaround time. Eurofins Viracor promises results within 24 hours of specimen receipt, which is a significant advantage for clinicians who need to monitor their patients' immune status closely. By reducing waiting times, the newly launched tests facilitate timely interventions and better overall outcomes for patients requiring rigorous post-transplant care.

Details of the Testing Process

The assays are based on EDTA plasma collection, which is minimally invasive, allowing for convenient sampling without significant discomfort to patients. Eurofins Viracor has established reliable shipping and stability protocols ensuring that the integrity of the samples is preserved from the point of collection to the laboratory. The assays are also available individually, or they can be combined into custom cytokine panels tailored to specific monitoring protocols and research requirements.

Comprehensive Transplant Solutions

Eurofins Viracor has built a reputation for providing extensive diagnostic expertise over the past four decades. With a wealth of knowledge in infectious disease, immunology, and allergy testing, the organization is committed to delivering precise, actionable results without losing sight of the important connection between the tests it conducts and the patients who rely on them.

With this expanded testing menu, healthcare providers can feel confident that they have the necessary tools at their disposal to monitor and manage their patients' health in a timely manner.

Contact Information for Further Inquiries

For clinicians and researchers interested in learning more about these assays and their potential applications in patient care, detailed information is readily available. Eurofins Viracor encourages interested parties to reach out to their Client Services team at (800) 305-5198. The team's expertise can provide deeper insight into how these assays can support and enhance immune monitoring workflows.

In this evolving field of transplant medicine and immunodeficiency care, the integration of new, effective testing methodologies is crucial. Eurofins Viracor is clearly positioning itself as a leader in this arena, contributing to improved care for vulnerable patient populations and expanding research opportunities across the medical community.